Achelios Therapeutics, Inc. — Form D
Achelios Therapeutics, Inc. of CHAPEL HILL, NC, a company, filed a Form D exempt-offering notice with the SEC on 2012-02-21. The offering totals $3.0M, of which $1.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-02-21
- Form: D
- Accession: 0001542874-12-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $3.0M
- Amount sold: $1.9M
- Remaining: $1.1M
- Minimum investment: $10K
- Investors: 22
- Date of first sale: 2012-02-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-173716
Issuer
- Name: Achelios Therapeutics, Inc.
- CIK: 0001542874
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 6340 QUADRANGLE DRIVE, CHAPEL HILL, NC, 27517
- Phone: 919-354-6233
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Crist Frangakis | Executive Officer | Chapel Hill, NC |
| Ron J Vered | Director | Ottowa, A6 |
| Crist J Frangakis | Director | Chapel Hill, NC |
| Crist J Frangakis | Executive Officer | Chapel Hill, NC |
| Jerry J Rosenblatt | Director | Mont-Royal, A8 |
| William J Dickie | Director | Chapel Hill, NC |
| William J Bauer | Director | Chapel Hill, NC |
Other filings by this issuer (2)
More